• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安非他命诱导行为效应拮抗作用:利莫那班在大鼠中的时程研究。

Antagonism of ∆⁹-THC induced behavioral effects by rimonabant: time course studies in rats.

机构信息

Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.

出版信息

Eur J Pharmacol. 2010 Dec 1;648(1-3):133-8. doi: 10.1016/j.ejphar.2010.09.006. Epub 2010 Sep 18.

DOI:10.1016/j.ejphar.2010.09.006
PMID:20854804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2954612/
Abstract

The objective was to examine the time course of the cannabinoid 1 receptor antagonist/inverse agonist rimonabant's ability to antagonize in vivo cannabinergic agonist effects. We used two behavioral procedures sensitive to the effects of ∆⁹-tetrahydrocannabinol (∆⁹-THC): rat drug discrimination (EXP-1) and suppression of fixed-ratio responding (FR) for food reinforcement (EXP-2). Two training doses of ∆⁹-THC (1.8 and 3 mg/kg) served as discriminative cues in two groups discriminating ∆⁹-THC from vehicle; injections were i.p. 20 min before session onset. Tests assessed the dose-response functions of ∆⁹-THC and the time course for rimonabant in its ability to block the discriminative stimulus effects of ∆⁹-THC. For antagonism testing, the training doses of ∆⁹-THC were used and the rimonabant dose was 1mg/kg. Tests were 20, 60, 120, and 240 min post rimonabant administration; ∆⁹-THC was always administered 20 min prior to testing. For EXP-2, only one response lever was activated and every 10th (FR-10) press on that lever resulted in food delivery. Once the response rate stabilized, tests occurred with ∆⁹-THC, rimonabant and combinations of the drugs. The ED(50) estimates for the dose-response functions were 0.38 (±0.28-0.51) and 0.50 (±0.40-0.63) mg/kg for the training doses of 1.8 and 3 mg/kg ∆⁹-THC, respectively. The time course studies suggested functional half-life estimates of 128.4 (±95.7-172.2) and 98.4 (±64.2-150.7) min by rimonabant for the two groups in EXP-1, respectively. Similarly, the functional half-life of rimonabant was 118.9 (±66.1-213.9) min in EXP-2. Thus, antagonism of ∆⁹-THC by rimonabant is relatively short lasting.

摘要

目的是研究大麻素 1 受体拮抗剂/反向激动剂利莫那班拮抗体内大麻素激动剂效应的时间过程。我们使用了两种对 ∆⁹-四氢大麻酚(∆⁹-THC)效应敏感的行为程序:大鼠药物辨别(EXP-1)和固定比例反应(FR)食物强化的抑制(EXP-2)。两个训练剂量的 ∆⁹-THC(1.8 和 3 mg/kg)作为两组辨别 ∆⁹-THC 与载体的辨别线索;注射在开始前 20 分钟进行。测试评估了 ∆⁹-THC 的剂量反应函数以及利莫那班阻断 ∆⁹-THC 辨别刺激效应的时间过程。对于拮抗作用测试,使用了训练剂量的 ∆⁹-THC,利莫那班的剂量为 1mg/kg。测试在利莫那班给药后 20、60、120 和 240 分钟进行;∆⁹-THC 总是在测试前 20 分钟给药。对于 EXP-2,只有一个反应杆被激活,每按压 10 次(FR-10)就会得到食物。一旦反应率稳定,就会进行 ∆⁹-THC、利莫那班和药物组合的测试。训练剂量为 1.8 和 3 mg/kg ∆⁹-THC 的剂量反应函数的 ED(50)估计值分别为 0.38(±0.28-0.51)和 0.50(±0.40-0.63)mg/kg。时间过程研究表明,利莫那班在 EXP-1 中的两个组的功能半衰期估计值分别为 128.4(±95.7-172.2)和 98.4(±64.2-150.7)分钟。类似地,利莫那班在 EXP-2 中的功能半衰期为 118.9(±66.1-213.9)分钟。因此,利莫那班拮抗 ∆⁹-THC 的作用相对短暂。

相似文献

1
Antagonism of ∆⁹-THC induced behavioral effects by rimonabant: time course studies in rats.安非他命诱导行为效应拮抗作用:利莫那班在大鼠中的时程研究。
Eur J Pharmacol. 2010 Dec 1;648(1-3):133-8. doi: 10.1016/j.ejphar.2010.09.006. Epub 2010 Sep 18.
2
JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.JWH-018 和 JWH-073:在猴子中具有 Δ⁹-四氢大麻酚样的辨别刺激效应。
J Pharmacol Exp Ther. 2012 Jan;340(1):37-45. doi: 10.1124/jpet.111.187757. Epub 2011 Sep 30.
3
Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.大麻素CB1受体拮抗剂利莫那班对大鼠的辨别性刺激作用。
Psychopharmacology (Berl). 2008 Jul;198(4):467-78. doi: 10.1007/s00213-008-1076-0. Epub 2008 Feb 9.
4
Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.在恒河猴辨别Δ9-四氢大麻酚的实验中,利莫那班与花生四烯乙醇胺及其化学类似物联合使用时的表观亲和力估计值。
Psychopharmacology (Berl). 2009 Apr;203(2):219-28. doi: 10.1007/s00213-008-1230-8. Epub 2008 Jul 1.
5
Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.大麻素CB1拮抗剂SR 141716A对经Δ9-四氢大麻酚预处理的恒河猴的辨别性刺激作用。
Psychopharmacology (Berl). 2006 Oct;188(3):306-14. doi: 10.1007/s00213-006-0500-6. Epub 2006 Sep 5.
6
Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.利莫那班诱导恒河猴体内大麻素的戒断:辨别刺激效应及其他戒断症状。
J Pharmacol Exp Ther. 2010 Jul;334(1):347-56. doi: 10.1124/jpet.110.168435. Epub 2010 Apr 7.
7
Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog.高亲和力CB1R选择性花生四烯酸乙醇胺类似物AM1346在大鼠中的辨别性刺激功能。
Psychopharmacology (Berl). 2009 Apr;203(2):229-39. doi: 10.1007/s00213-008-1199-3. Epub 2008 Jun 3.
8
(R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.(R)-甲烷酰胺和Δ9-四氢大麻酚作为大鼠的辨别性刺激物:大麻素拮抗剂SR-141716和内源性配体花生四烯乙醇胺的测试
Psychopharmacology (Berl). 2001 Aug;156(4):369-80. doi: 10.1007/s002130100730.
9
The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys.大麻素激动剂HU - 210:恒河猴中的拟不可逆辨别刺激效应
Eur J Pharmacol. 2014 Mar 15;727:35-42. doi: 10.1016/j.ejphar.2014.01.041. Epub 2014 Jan 30.
10
Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.使用大鼠药物辨别实验方案区分低效和高效能CB1受体激动剂。
Psychopharmacology (Berl). 2014 Feb;231(3):489-500. doi: 10.1007/s00213-013-3257-8. Epub 2013 Sep 5.

引用本文的文献

1
Discriminating evidence - use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs.鉴别性证据——药物辨别试验在新型中枢神经系统药物滥用潜力评估中的使用与误用
J Psychopharmacol. 2025 Jul;39(7):629-651. doi: 10.1177/02698811251330780. Epub 2025 Apr 17.
2
A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.对天然和合成大麻素的滥用、依赖性及相关安全风险的批判性评估。
Front Psychiatry. 2024 Jun 10;15:1322434. doi: 10.3389/fpsyt.2024.1322434. eCollection 2024.
3
The CB1 negative allosteric modulator PSNCBAM-1 reduces ethanol self-administration via a nonspecific hypophagic effect.

本文引用的文献

1
Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol.大麻酚和 δ(9)-四氢大麻酚在大鼠中的辨别刺激功能:氨基烷基吲哚(WIN55,212-2 和 AM678)和乙醇的测试。
Psychopharmacology (Berl). 2010 Jan;208(1):87-98. doi: 10.1007/s00213-009-1708-z. Epub 2009 Nov 10.
2
Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.δ9-四氢大麻酚(THC)在C57Bl/6J小鼠中的辨别性刺激特性。
Eur J Pharmacol. 2009 Aug 1;615(1-3):102-7. doi: 10.1016/j.ejphar.2009.05.010. Epub 2009 May 23.
3
The future of endocannabinoid-oriented clinical research after CB1 antagonists.
CB1 负变构调节剂 PSNCBAM-1 通过非特异性的食欲减退作用减少乙醇的自我给药。
Pharmacol Biochem Behav. 2024 Jul;240:173776. doi: 10.1016/j.pbb.2024.173776. Epub 2024 Apr 27.
4
Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults.与成年人不同,Δ9-四氢大麻酚不会上调青少年大脑中的厌恶多巴胺受体机制。
Curr Res Neurobiol. 2023 Sep 4;5:100107. doi: 10.1016/j.crneur.2023.100107. eCollection 2023.
5
Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats.大鼠慢性被动吸入大麻烟雾后四氢大麻酚诱导的大麻素依赖的药代动力学和药效学特征
Cannabis Cannabinoid Res. 2019 Dec 6;4(4):240-254. doi: 10.1089/can.2019.0049. eCollection 2019.
6
The novel cannabinoid CB receptor agonist AM11101 increases food intake in female rats.新型大麻素 CB 受体激动剂 AM11101 增加雌性大鼠的食物摄入量。
Br J Pharmacol. 2019 Oct;176(20):3972-3982. doi: 10.1111/bph.14797. Epub 2019 Sep 6.
7
Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant.同时定量检测大麻素四氢大麻酚、大麻二酚和 CB1 受体拮抗剂在大鼠血浆中的浓度:一种应用于被动吸食大麻烟雾和同时给予利莫那班后的药代动力学特征描述的方法。
J Pharm Biomed Anal. 2018 Oct 25;160:119-125. doi: 10.1016/j.jpba.2018.07.004. Epub 2018 Jul 19.
8
Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.人类药物辨别:阐明常见滥用非法药物的神经药理学
Curr Top Behav Neurosci. 2018;39:261-295. doi: 10.1007/7854_2016_10.
9
Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model.使用改良的操作性自我给药模型对大鼠乙醇和水饮用模式的微观结构分析。
Physiol Behav. 2015 Oct 1;149:119-30. doi: 10.1016/j.physbeh.2015.05.034. Epub 2015 May 31.
10
Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite.油酰乙醇胺:一种用于控制食欲的新型潜在药理学替代物,可替代大麻素拮抗剂。
Biomed Res Int. 2014;2014:203425. doi: 10.1155/2014/203425. Epub 2014 Apr 3.
CB1拮抗剂之后以内源性大麻素为导向的临床研究的未来。
Psychopharmacology (Berl). 2009 Jul;205(1):171-4. doi: 10.1007/s00213-009-1506-7. Epub 2009 Mar 20.
4
Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.AM4113(一种假定的中性CB1受体选择性拮抗剂)对大鼠旷场行为的内在影响。
Pharmacol Biochem Behav. 2008 Nov;91(1):84-90. doi: 10.1016/j.pbb.2008.06.014. Epub 2008 Jun 29.
5
Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog.高亲和力CB1R选择性花生四烯酸乙醇胺类似物AM1346在大鼠中的辨别性刺激功能。
Psychopharmacology (Berl). 2009 Apr;203(2):229-39. doi: 10.1007/s00213-008-1199-3. Epub 2008 Jun 3.
6
Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.大麻素激动剂在C57BL/6J小鼠中对Δ⁹-四氢大麻酚的辨别刺激效应有不同程度的替代作用。
Psychopharmacology (Berl). 2008 Jul;198(4):487-95. doi: 10.1007/s00213-007-0900-2. Epub 2007 Aug 3.
7
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users.单剂量和多剂量的利莫那班可拮抗男性大麻使用者吸食大麻的急性效应。
Psychopharmacology (Berl). 2007 Nov;194(4):505-15. doi: 10.1007/s00213-007-0861-5. Epub 2007 Jul 10.
8
Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.大麻素CB1受体反向激动剂和中性拮抗剂:对食物摄入、食物强化行为及食物厌恶的影响。
Physiol Behav. 2007 Jul 24;91(4):383-8. doi: 10.1016/j.physbeh.2007.04.013. Epub 2007 Apr 14.
9
Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).在接受Δ9-四氢大麻酚或(R)-甲磺酰胺(AM-356)训练的大鼠中,CB1R选择性花生四烯乙醇胺类似物AM-1346的辨别性刺激功能。
Psychopharmacology (Berl). 2006 Oct;188(3):315-23. doi: 10.1007/s00213-006-0517-x. Epub 2006 Sep 5.
10
Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.大鼠中δ9-四氢大麻酚和(R)-甲胺基甲酰基磷酸的辨别性刺激效应的拮抗作用
Psychopharmacology (Berl). 2006 Jan;184(1):36-45. doi: 10.1007/s00213-005-0225-y. Epub 2005 Nov 24.